Adversity Index for Clinical Trials: An Inclusive Approach for Analysis of Safety Data
Sharayu Paranjpe, Anil Gore
TL;DR
This paper introduces a novel adversity index for analyzing safety data in clinical trials, demonstrated through applications to breast cancer and diabetes phase III trial data.
Contribution
The paper presents an innovative adversity index method for safety data analysis in clinical trials, enhancing inclusivity and interpretability.
Findings
Effective application to breast cancer trials
Effective application to diabetes trials
Improved safety data analysis approach
Abstract
This paper proposes a new method for analysis of adverse event data in clinical trials. The method is illustrated by application to data on 4 phase III clinical trials, two on breast cancer and two on diabetes mellitus.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods in Clinical Trials · Health Systems, Economic Evaluations, Quality of Life · Advanced Causal Inference Techniques